Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen adherence to epithelial cells is the essential first step in the establishment of most infectious diseases, involving the binding of microbial adhesins to host cell receptors (PubMed: 11544353). This process allows pathogens to resist physical clearance by host fluids and facilitates the delivery of virulence factors or cellular invasion (NIH: PMC7150056). In clinical practice, this mechanism is a target for anti-adhesion therapies, such as D-mannose for preventing E. coli attachment in urinary tract infections or monoclonal antibodies like Palivizumab that block viral adherence (PubChem: CID 135314758). By inhibiting these initial interactions, drugs can prevent colonization without necessarily killing the pathogen, potentially reducing the drive for antibiotic resistance (PubMed: 28803815). This target represents a broad biological mechanism rather than a single molecular entity, encompassing various protein-protein and protein-carbohydrate interactions.
Competitive inhibition of microbial adhesins or host cell receptors to prevent attachment and colonization.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen adherence to epithelial cells.